- Home
- NPCE vs EIC Comparison
NPCE vs EIC Comparison
Compare NPCE & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- EIC
- Stock Information
- Founded
- NPCE 1997
- EIC N/A
- Country
- NPCE United States
- EIC United States
- Employees
- NPCE N/A
- EIC N/A
- Industry
- NPCE Medical Specialities
- EIC Finance/Investors Services
- Sector
- NPCE Health Care
- EIC Finance
- Exchange
- NPCE Nasdaq
- EIC Nasdaq
- Market Cap
- NPCE 328.8M
- EIC 334.1M
- IPO Year
- NPCE 2021
- EIC 2019
- Fundamental
- Price
- NPCE $9.38
- EIC $12.42
- Analyst Decision
- NPCE Strong Buy
- EIC
- Analyst Count
- NPCE 6
- EIC 0
- Target Price
- NPCE $16.67
- EIC N/A
- AVG Volume (30 Days)
- NPCE 121.6K
- EIC 146.1K
- Earning Date
- NPCE 11-04-2025
- EIC 11-13-2025
- Dividend Yield
- NPCE N/A
- EIC 12.43%
- EPS Growth
- NPCE N/A
- EIC N/A
- EPS
- NPCE N/A
- EIC 0.70
- Revenue
- NPCE $88,570,000.00
- EIC $55,581,156.00
- Revenue This Year
- NPCE $22.13
- EIC $37.84
- Revenue Next Year
- NPCE $6.07
- EIC $23.33
- P/E Ratio
- NPCE N/A
- EIC $18.03
- Revenue Growth
- NPCE 23.32
- EIC 56.39
- 52 Week Low
- NPCE $6.03
- EIC $12.10
- 52 Week High
- NPCE $18.98
- EIC $16.71
- Technical
- Relative Strength Index (RSI)
- NPCE 35.09
- EIC 42.24
- Support Level
- NPCE $9.22
- EIC $12.65
- Resistance Level
- NPCE $10.81
- EIC $12.98
- Average True Range (ATR)
- NPCE 0.44
- EIC 0.23
- MACD
- NPCE -0.18
- EIC 0.04
- Stochastic Oscillator
- NPCE 6.09
- EIC 41.84
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.